Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BCAT-IN-2
Cat. No.:
OB0425LY-131
Appearance:
Solid
Purity:
99.07%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
BCAT-IN-2 is a novel biochemical inhibitor that specifically targets branch chain amino acid transaminases (BCAT). BCAT inhibition affects amino acid metabolism, which regulates energy homeostasis.
Synonyms:
1800024-45-6; 2-((4-Chloro-2,6-difluorobenzyl)amino)-7-oxo-5-propyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile; 2-[(4-Chloro-2,6-difluorophenyl)methylamino]-7-oxo-5-propyl-1H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile
CAS No.:
1800024-45-6
Compound CID:
78319104
Formula:
C17H14ClF2N5O
Formula Weight:
377.78
Specification
Target:
Aminotransferases (Transaminases)
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
BCAT-IN-2 is mainly used in the study of metabolism-related diseases and has potential applications especially in therapeutic studies of diabetes and obesity.
